Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) has shared an update.
Beijing Biostar Pharmaceuticals Co., Ltd. has released a supplemental announcement regarding its employee incentive schemes as part of its 2024 annual report. The announcement details the granted awards under various employee incentive schemes, highlighting the vesting schedules and performance conditions required for unlocking these awards. The company emphasizes its adherence to corporate governance measures to manage potential conflicts of interest and protect shareholder interests.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a joint stock company incorporated in China, operating in the pharmaceutical industry. The company focuses on developing and manufacturing biological and medical products, catering to the healthcare sector.
Average Trading Volume: 247,649
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$661M
Find detailed analytics on 2563 stock on TipRanks’ Stock Analysis page.